Prescribing data, metrics or supporting resources
Bruyère Research Institute Deprescribing Guidelines Research Team has produced a benzodiazepine and Z-drug deprescribing algorithm that supports recommendations in the NICE guidance on the use of zolpidem and zopiclone for the short-term management of insomnia, and medicines optimisation.
The selection of metrics to support key therapeutic topics is overseen by the NHS England Medicines Optimisation Intelligence Group, and work is ongoing in this area. At this point, the following metrics and prescribing data have been identified by this group to support this topic.
A medicines optimisation key therapeutic topic prescribing comparator is available – Hypnotics ADQ/STAR PU (ADQ based).
The Medicines optimisation dashboard, which brings together a range of medicines-related metrics from across sectors, includes this comparator. It helps NHS organisations to understand how well their local populations are being supported to optimise medicines use and inform local planning. The dashboard allows NHS organisations to highlight variation in local practice and provoke discussion on the appropriateness of local care. It is not intended as a performance measurement tool and there are no targets.
Prescription Cost Analysis data of prescriptions dispensed in the community in England show that in 2017, 834,793 items of melatonin were dispensed at a cost of approximately £34 million. These data relate to all melatonin preparations, including 'specials', for all indications.